Related references
Note: Only part of the references are listed.The 2009 A (H1N1) influenza virus pandemic: A review
Marc P. Girard et al.
VACCINE (2010)
Current status and progress of prepandemic and pandemic influenza vaccine development
Isabel Leroux-Roels et al.
EXPERT REVIEW OF VACCINES (2009)
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Angelika Banzhoff et al.
PLOS ONE (2009)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
Daniel Wai-Sing Chu et al.
VACCINE (2009)
Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
Tino F. Schwarz et al.
VACCINE (2009)
Type I interferon as a stimulus for cross-priming
Agnes Le Bon et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Standardization and Optimization of Multiparameter Intracellular Cytokine Staining
Laurel Nomura et al.
CYTOMETRY PART A (2008)
Vaccine adjuvants alter TCR-based selection thresholds
Laurent Malherbe et al.
IMMUNITY (2008)
Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages
Roza I. Nurieva et al.
IMMUNITY (2008)
An adjuvanted, low-dose, pandemic influenza a (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults
Karin Levie et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
David I. Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1
Iain Stephenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
Isabel Leroux-Roels et al.
PLOS ONE (2008)
Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
Benoit Baras et al.
PLOS ONE (2008)
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
Hans C. Rumke et al.
VACCINE (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung
Godelieve J. de Bree et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization
Cristina Cellerai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Influenza and the challenge for immunology
PC Doherty et al.
NATURE IMMUNOLOGY (2006)
Protein vaccines induce uncommitted IL-2-secreting human and mousle CD4 T cells, whereas infections induce more IFN-γ-secreting cells
AA Divekar et al.
JOURNAL OF IMMUNOLOGY (2006)
CD4(+) T-cell memory: generation and multi-faceted roles for CD4(+) T cells in protective immunity to influenza
Susan L. Swain et al.
IMMUNOLOGICAL REVIEWS (2006)
Understanding the generation and function of memory T cell subsets
A Lanzavecchia et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
C Nicolson et al.
VACCINE (2005)
Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines
RJ Webby et al.
LANCET (2004)
Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system
S Crotty et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Memory CD8 T-cell differentiation during viral infection
EJ Wherry et al.
JOURNAL OF VIROLOGY (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Share Paper
